Back to Experts

David Strain

Associate Professor in Cardiometabolic in the Diabetes and Vascular Research Centre at the University of Exeter Medical School


David Strain

Prof in Cardiometabolic Health

Chair of British Medical Association Board of Science and Academic Staff Committee

Co-Clinical and Academic Lead of the Healthcare for Older People department

University of Exeter Medical School, UK

 

David Strain is an Associate Professor in Cardiometabolic at the Diabetes and Vascular Research Centre at the University of Exeter Medical School, with expertise in microvascular structure and function. Clinically, he runs a community service for older adults with diabetes and/or cardiovascular disease and works as an in-patient consultant.

His main focus is the health of older adults with diabetes; ensuring the right patient gets the right treatment. This includes research exploring the mechanism that some medications, specifically the SGLT-2 inhibitors and GLP-1 analogues, give benefits to people with diabetes, heart disease and renal failure beyond their effect on sugar and blood pressure. The hope is we can identify those who would benefit most before arising. He has performed the only study to date demonstrating the feasibility of individualizing targets for older adults across Europe. As a result, he led the stakeholders group that produced the UK guidelines for the management of older adults with type 2 diabetes that informed the new UK NICE guidance and modification to the Quality Outcome Framework.

Since April 2019, he has also been running a COVID service as clinical lead in COVID for Exeter, been involved in the national Long COVID taskforce, and established research into the underlying causes and potential cures.

We work with more than 200 leading Life Sciences companies including:

Working with Life Science Access Academy, our company love the variety of the many courses that are on offer. The hour long courses on specific subjects are really useful on Friday lunchtimes for our field teams and gain a lot of interest.

Life Science Access Academy are also super flexible and helpful when it comes to tailoring some additional sessions to our needs.

Marsha Gray, Training Specialist

Boehringer Ingelheim Ltd

We have been partnered with LSAA for several years now which has enabled our team members to develop their competencies and capabilities.

With over 700 learning modules, regular webinars on highly relevant topics across the UK, the opportunity to engage with expert speakers after events and regular blogs and newsletters, the platform is a highly valued resource at Ferring.

The team also provides regular usage statistics so we can understand the hot topics in Ferring and enable colleagues to share knowledge and experience with each other.

Paul Runeckles, Director of Execution Excellence

Ferring

Frontier Medical has fully implemented, Life Science Access Academy allowing Sales and Marketing to utilise the system. Maximising on line learning for all remote staff stimulates a culture of self-development giving individuals the accountability and responsibility to broaden their skills set.

Life Science Access Academy training is topical and a good fit for the faced paced healthcare market.

Simon Warden, National Sales Manager

Frontier Medical Group

I have found the training via the Life Science Access Academy to be excellent and I know many of my colleagues have as well.

The content is always kept up to date and there is huge and interesting variety of topics covered. The site is curated in a way that makes it clear and easy to navigate. Also, the staff at Life Science access Academy are friendly and responsive and all the experts are always knowledgeable in their areas.

Richard Edmonds

Gedeon Richter Women's Health

The variety and relevancy of content brings value to many different roles across the healthcare industry.

I have also been overwhelmed by the way the Life Science Access Academy team have accommodated our own business needs, being sensitive yet responsive to helping us since its formation.

Robb Sayers, UK Capability Lead

ViiV Healthcare